- Home
- CLPS vs VTVT Comparison
CLPS vs VTVT Comparison
Compare CLPS & VTVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLPS
- VTVT
- Stock Information
- Founded
- CLPS 2005
- VTVT 2015
- Country
- CLPS Hong Kong
- VTVT United States
- Employees
- CLPS N/A
- VTVT N/A
- Industry
- CLPS Computer Software: Prepackaged Software
- VTVT Biotechnology: Pharmaceutical Preparations
- Sector
- CLPS Technology
- VTVT Health Care
- Exchange
- CLPS Nasdaq
- VTVT Nasdaq
- Market Cap
- CLPS 38.4M
- VTVT 31.9M
- IPO Year
- CLPS 2018
- VTVT 2015
- Fundamental
- Price
- CLPS $1.10
- VTVT $17.40
- Analyst Decision
- CLPS
- VTVT
- Analyst Count
- CLPS 0
- VTVT 0
- Target Price
- CLPS N/A
- VTVT N/A
- AVG Volume (30 Days)
- CLPS 64.4K
- VTVT 49.5K
- Earning Date
- CLPS 10-18-2024
- VTVT 11-12-2024
- Dividend Yield
- CLPS 11.82%
- VTVT N/A
- EPS Growth
- CLPS N/A
- VTVT N/A
- EPS
- CLPS N/A
- VTVT N/A
- Revenue
- CLPS $142,812,726.00
- VTVT $1,000,000.00
- Revenue This Year
- CLPS N/A
- VTVT N/A
- Revenue Next Year
- CLPS N/A
- VTVT N/A
- P/E Ratio
- CLPS N/A
- VTVT N/A
- Revenue Growth
- CLPS N/A
- VTVT 11011.11
- 52 Week Low
- CLPS $0.68
- VTVT $7.38
- 52 Week High
- CLPS $1.70
- VTVT $30.99
- Technical
- Relative Strength Index (RSI)
- CLPS 40.34
- VTVT 68.44
- Support Level
- CLPS $1.02
- VTVT $12.62
- Resistance Level
- CLPS $1.20
- VTVT $15.40
- Average True Range (ATR)
- CLPS 0.14
- VTVT 1.02
- MACD
- CLPS -0.03
- VTVT 0.30
- Stochastic Oscillator
- CLPS 33.33
- VTVT 84.01
About CLPS CLPS Incorporation
CLPS Inc is a holding company. The company through its subsidiaries provides information technology consulting and solutions institutions in banking, insurance, and financial sectors, both in China and globally. Its products are Risk Control Platform, Transaction Acquiring Platform, Debt Collection Platform, Virtual Bank Training Platform, Credit Card System, and other related products. The company generates its revenue from IT consulting service, Customized IT solution service, and other. Generating majority of its revenue from the IT consulting service.
About VTVT vTv Therapeutics Inc.
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Itsproduct pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.